BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18681895)

  • 21. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel factor required for the SUMO1/Smt3 conjugation of yeast septins.
    Takahashi Y; Toh-e A; Kikuchi Y
    Gene; 2001 Sep; 275(2):223-31. PubMed ID: 11587849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45.
    Sekiyama N; Arita K; Ikeda Y; Hashiguchi K; Ariyoshi M; Tochio H; Saitoh H; Shirakawa M
    Proteins; 2010 May; 78(6):1491-502. PubMed ID: 20077568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation and nuclear export of preribosomes are functionally linked to the small-ubiquitin-related modifier pathway.
    Panse VG; Kressler D; Pauli A; Petfalski E; Gnädig M; Tollervey D; Hurt E
    Traffic; 2006 Oct; 7(10):1311-21. PubMed ID: 16978391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMO-1 modification of the Wilms' tumor suppressor WT1.
    Smolen GA; Vassileva MT; Wells J; Matunis MJ; Haber DA
    Cancer Res; 2004 Nov; 64(21):7846-51. PubMed ID: 15520190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tools to Study SUMO Conjugation in Caenorhabditis elegans.
    Pelisch F; Hay RT
    Methods Mol Biol; 2016; 1475():233-56. PubMed ID: 27631810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
    Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
    Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies.
    Sharma P; Murillas R; Zhang H; Kuehn MR
    J Cell Sci; 2010 Apr; 123(Pt 8):1227-34. PubMed ID: 20233849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SUMO regulates p21Cip1 intracellular distribution and with p21Cip1 facilitates multiprotein complex formation in the nucleolus upon DNA damage.
    Brun S; Abella N; Berciano MT; Tapia O; Jaumot M; Freire R; Lafarga M; Agell N
    PLoS One; 2017; 12(6):e0178925. PubMed ID: 28582471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
    Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
    J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
    Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
    J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
    Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
    Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
    Weger S; Hammer E; Engstler M
    Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sumoylation modulates the assembly and activity of the pre-mRNA 3' processing complex.
    Vethantham V; Rao N; Manley JL
    Mol Cell Biol; 2007 Dec; 27(24):8848-58. PubMed ID: 17923699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A global S. cerevisiae small ubiquitin-related modifier (SUMO) system interactome.
    Srikumar T; Lewicki MC; Raught B
    Mol Syst Biol; 2013 May; 9():668. PubMed ID: 23712011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligation independent cloning vectors for expression of SUMO fusions.
    Weeks SD; Drinker M; Loll PJ
    Protein Expr Purif; 2007 May; 53(1):40-50. PubMed ID: 17251035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase recruitment domain of procaspase-2 could be a target for SUMO-1 modification through Ubc9.
    Shirakura H; Hayashi N; Ogino S; Tsuruma K; Uehara T; Nomura Y
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1007-15. PubMed ID: 15882978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.